Loading company…
NEUROPLUS develops non-invasive neuromodulation technology and treatments for brain function disorders.
NEUROPLUS researches and develops non-invasive closed-loop neuromodulation for prevention, treatment, and rehabilitation of brain function disorders. Its solutions include transcranial electrical stimulators and are intended for conditions such as cognitive impairment, Alzheimer's disease, and disorders of consciousness. Established in 2018, the company is based in Shenzhen, China. It closed pre-Series A and pre-Series A+ funding in November 2024.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in